Preserving Well-being in Patients With Advanced and Late Prostate Cancer

被引：0

作者：

Handley, Nathan R.

Feng, Felix Y.

Guise, Theresa A.

D'Andrea, Denise

Kelly, William Kevin

Gomella, Leonard G.

机构：

[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA

[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Radiat Oncol, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Urol, San Francisco, CA 94143 USA

[4] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Med, San Francisco, CA 94143 USA

[5] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA

[6] Janssen Sci Affairs LLC, Horsham, PA USA

[7] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Urol, Philadelphia, PA 19107 USA

来源：

UROLOGY | 2021年 / 155卷

关键词：

ANDROGEN-DEPRIVATION THERAPY; ACETATE PLUS PREDNISONE; ABIRATERONE ACETATE; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; AMERICAN-SOCIETY; DOUBLE-BLIND; BONE-HEALTH; OLDER MEN; RISK;

D O I：

10.1016/j.urology.2020.12.018

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Androgen deprivation therapy, alone or in combination with androgen signaling inhibitors, is a treatment option for patients with advanced prostate cancer (PC). When making treatment decisions, health care providers must consider the long-term effects of treatment on the patient's overall health and well-being. Herein, we review the effects of these treatments on the musculoskeletal and cardiovascular systems, cognition, and fall risk, and provide management approaches for each. We also include an algorithm to help health care providers implement best clinical practices and interdisciplinary care for preserving the overall well-being of PC patients. (C) 2020 Elsevier Inc.

引用

页码：199 / 209

页数：11

共 84 条

[1] Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study [J].

Agarwal, Neeraj ;

McQuarrie, Kelly ;

Bjartell, Anders ;

Chowdhury, Simon ;

Pereira de Santana Gomes, Andrea J. ;

Chung, Byung Ha ;

Ozguroglu, Mustafa ;

Juarez Soto, Alvaro ;

Merseburger, Axel S. ;

Uemura, Hirotsugu ;

Ye, Dingwei ;

Given, Robert ;

Cella, David ;

Basch, Ethan ;

Miladinovic, Branko ;

Dearden, Lindsay ;

Deprince, Kris ;

Naini, Vahid ;

Lopez-Gitlitz, Angela ;

Chi, Kim N. .

LANCET ONCOLOGY, 2019, 20 (11) :1518-1530

[2]

Agency for Healthcare Research and Quality, TOOL 3G STRATIFY SCA

[3]

AHI of Indiana, HENDR 2 FALL RISK MO

[4]

[Anonymous], Clinical Practice Guidelines in Oncology (NCCN Guidelines)

[5]

[Anonymous], 2020, XTANDI ENZ PRESCR IN

[6]

[Anonymous], 2020, ERLEADA AP PRESCR IN

[7]

[Anonymous], 2019, ZYTIGA AB AC PRESCR

[8] ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer [J].

Armstrong, Andrew J. ;

Szmulewitz, Russell Z. ;

Petrylak, Daniel P. ;

Holzbeierlein, Jeffrey ;

Villers, Arnauld ;

Azad, Arun ;

Alcaraz, Antonio ;

Alekseev, Boris ;

Iguchi, Taro ;

Shore, Neal D. ;

Rosbrook, Brad ;

Sugg, Jennifer ;

Baron, Benoit ;

Chen, Lucy ;

Stenzl, Arnulf .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (32) :2974-+

[9]

Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010, 10.1016/j.jacc.2019.03.009]

[10] Validity of the Morse Fall Scale implemented in an electronic medical record system [J].

Baek, Seonhyeon ;

Piao, Jinshi ;

Jin, Yinji ;

Lee, Sun-Mi .

JOURNAL OF CLINICAL NURSING, 2014, 23 (17-18) :2434-2441

← 1 2 3 4 5 6 7 8 9 →